4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-17-045842
SVP & Chief Medical Officer sold 54,920 shares at $21.10 ($1,158,812)
- SVP & Chief Medical Officer acquired 54,920 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gergel Ivan P. SVP & Chief Medical Officer | 2017-07-18 | Option exercise | +54,920 | $11.04 | $606,317 | 98,492 | D: show line 1 in the form |
| Gergel Ivan P. SVP & Chief Medical Officer | 2017-07-18 | Sale | −54,920 | $21.10 | $1,158,812 | 43,572 | D: show line 2 in the form |
| Open-market sales · 54,920 sh · avg $21.10 · $1,158,812 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Gergel Ivan P. SVP & Chief Medical Officer | 2017-07-18 | Option exercise · Stock Option | −54,920 | 413,752 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…